AIM: To investigate the effects of a selective inhibitor of Rho-associated kinase (ROCK), Y-27632, on inbred Wuzhishan porcine corneal endothelial cells (PCECs) in vitro and in vivo studies. METHODS: Primary PCECs were trypsinized from Wuzhishan miniature porcine corneal tissues. The optimal concentration of Y-27632 on PCECs was determined through MTT and 5-ethynyl-2'-deoxyuridine (EdU)-labeling assays. Seven New Zealand rabbits were used as a corneal endothelial dysfunction model, and a PCECs suspension supplemented with Y-27632 was injected into the anterior chamber of the rabbits. The progression of rabbit corneal opacity and edema were observed by slit lamp examination. The rabbits were sacrificed, and rabbit globes were enucleated for trypan blue-alizarin red staining, hematoxylineosin staining, and immunofluorescence analysis. RESULTS: Administration of 100 mu mol/L Y-27632 facilitated PCECs' proliferation obviously. The rabbit corneas injected with PCECs suspension and 100 mu mol/L Y-27632 were restored to transparency significantly after 14d. CONCLUSION: The 100 mu mol/L Y-27632 treatment improves PCECs' proliferation significantly. And our results suggest that Y-27632 and PCECs can be used to treat corneal endothelial dysfunction.
基金:
National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81470608]
第一作者机构:[1]Shanxi Eye Hosp, Taiyuan 030002, Shanxi, Peoples R China[2]Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Ophthalmol & Visual Sci Key Lab, Dongjiaominxiang 1, Beijing 100730, Peoples R China
通讯作者:
通讯机构:[2]Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Ophthalmol & Visual Sci Key Lab, Dongjiaominxiang 1, Beijing 100730, Peoples R China[*1]Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology and Visual Science Key Laboratory, Dongjiaominxiang 1#, Dongcheng District, Beijing 100730, China
推荐引用方式(GB/T 7714):
Song Yao-Wen,Chen Jun-Yu,Li Xu,et al.Therapeutic potential of Rho-associated kinase inhibitor Y27632 in corneal endothelial dysfunction: an in vitro and in vivo study[J].INTERNATIONAL JOURNAL OF OPHTHALMOLOGY.2021,14(1):19-25.doi:10.18240/ijo.2021.01.03.
APA:
Song, Yao-Wen,Chen, Jun-Yu,Li, Xu,Wang, Li&Pan, Zhi-Qiang.(2021).Therapeutic potential of Rho-associated kinase inhibitor Y27632 in corneal endothelial dysfunction: an in vitro and in vivo study.INTERNATIONAL JOURNAL OF OPHTHALMOLOGY,14,(1)
MLA:
Song, Yao-Wen,et al."Therapeutic potential of Rho-associated kinase inhibitor Y27632 in corneal endothelial dysfunction: an in vitro and in vivo study".INTERNATIONAL JOURNAL OF OPHTHALMOLOGY 14..1(2021):19-25